176 related articles for article (PubMed ID: 34401137)
1. Hypercalcemia of malignancy in metastatic esophageal squamous cell carcinoma with simultaneous PTHrP and calcitriol overproduction: A case report with literature review.
Song R; Bijay Y; Rizk SH; Cao S
Ann Med Surg (Lond); 2021 Aug; 68():102667. PubMed ID: 34401137
[TBL] [Abstract][Full Text] [Related]
2. Hypercalcemia of Malignancy and Colorectal Cancer.
Galindo RJ; Romao I; Valsamis A; Weinerman S; Harris YT
World J Oncol; 2016 Feb; 7(1):5-12. PubMed ID: 26998187
[TBL] [Abstract][Full Text] [Related]
3. Zoledronate-responsive calcitriol-mediated hypercalcemia in a 5-year-old case with squamous cell carcinoma on the background of xeroderma pigmentosum.
Colak U; Mutlu GY; Sozmen BO; Yucel EB; Kayserili H; Hatun S
J Pediatr Endocrinol Metab; 2019 Dec; 32(12):1403-1406. PubMed ID: 31782950
[TBL] [Abstract][Full Text] [Related]
4. Hypercalcemia in non-Hodgkin's lymphoma due to cosecretion of PTHrP and 1,25-dihydroxyvitamin D.
Gonciulea AR; Wang Y; Bikle DD; Sellmeyer DE
Osteoporos Int; 2021 Dec; 32(12):2587-2592. PubMed ID: 34230999
[TBL] [Abstract][Full Text] [Related]
5. Calcitriol Elevation Is Associated with a Higher Risk of Refractory Hypercalcemia of Malignancy in Solid Tumors.
Chukir T; Liu Y; Hoffman K; Bilezikian JP; Farooki A
J Clin Endocrinol Metab; 2020 Apr; 105(4):e1115-23. PubMed ID: 31841590
[TBL] [Abstract][Full Text] [Related]
6. Calcitriol induced hypercalcemia - a rare phenomenon in lung cancer: A case report.
Prakash A; Khalid F; Alalwan A; Bader H; Du D; Meghal T
World J Clin Oncol; 2023 Nov; 14(11):544-548. PubMed ID: 38059187
[TBL] [Abstract][Full Text] [Related]
7. Hypercalcemia of Malignancy: Simultaneous Elevation in Parathyroid Hormone-Related Peptide and 1,25 Dihydroxyvitamin D in Sarcoma.
Kim DW; Miller A; Li A; Hardy N; Silver KD
AACE Clin Case Rep; 2021; 7(3):169-173. PubMed ID: 34095480
[TBL] [Abstract][Full Text] [Related]
8. Hypercalcemia of Malignancy Attributed to Cosecretion of PTH and PTHRP in Lung Adenocarcinoma.
Kroopnick JM; Martinez-Outschoorn U; Tuluc M; Kim CS
AACE Clin Case Rep; 2021; 7(3):200-203. PubMed ID: 34095488
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis, Pathophysiology and Management of Hypercalcemia in Malignancy: A Review of the Literature.
Asonitis N; Angelousi A; Zafeiris C; Lambrou GI; Dontas I; Kassi E
Horm Metab Res; 2019 Dec; 51(12):770-778. PubMed ID: 31826272
[TBL] [Abstract][Full Text] [Related]
10. Hypercalcemia and Renal Mass: A Diagnostically Challenging Case.
Karki S; Galiveeti S; Leung V
Cureus; 2021 Jul; 13(7):e16718. PubMed ID: 34513354
[TBL] [Abstract][Full Text] [Related]
11. Malignant Hypercalcemia Due to the Ectopic Production of Calcitriol by an Abdominal Liposarcoma.
Figueiredo A; Pereira T; Cabrera R; Simões-Pereira J; Leite V
Cureus; 2023 Jan; 15(1):e33446. PubMed ID: 36751194
[TBL] [Abstract][Full Text] [Related]
12. Hypercalcemia in Lung Cancer due to Simultaneously Elevated PTHrP and Ectopic Calcitriol Production: First Case Report.
Nemr S; Alluri S; Sundaramurthy D; Landry D; Braden G
Case Rep Oncol Med; 2017; 2017():2583217. PubMed ID: 28751994
[TBL] [Abstract][Full Text] [Related]
13. Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report.
Johnson K; Issa M; Parikh A; Monk P; Yin M; Mortazavi A; Yang Y
BMC Urol; 2021 Apr; 21(1):51. PubMed ID: 33794867
[TBL] [Abstract][Full Text] [Related]
14. Hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumors (PTHrP-PNETs): Case Report.
Pitts S; Mahipal A; Bajor D; Mohamed A
Front Oncol; 2023; 13():1197288. PubMed ID: 37377908
[TBL] [Abstract][Full Text] [Related]
15. Hypercalcemia of malignancy and new treatment options.
Sternlicht H; Glezerman IG
Ther Clin Risk Manag; 2015; 11():1779-88. PubMed ID: 26675713
[TBL] [Abstract][Full Text] [Related]
16. Conflicting actions of parathyroid hormone-related protein and serum calcium as regulators of 25-hydroxyvitamin D(3)-1 alpha-hydroxylase expression in a nude rat model of humoral hypercalcemia of malignancy.
Michigami T; Yamato H; Suzuki H; Nagai-Itagaki Y; Sato K; Ozono K
J Endocrinol; 2001 Nov; 171(2):249-57. PubMed ID: 11691644
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone-related protein, parathyroid hormone, and vitamin D in hypercalcemia of malignancy.
Motellón JL; Javort Jiménez F; de Miguel F; Jaras MJ; Díaz A; Hurtado J; Esbrit P
Clin Chim Acta; 2000 Jan; 290(2):189-97. PubMed ID: 10660809
[TBL] [Abstract][Full Text] [Related]
18. PTHrP-mediated hypercalcemia: causes and survival in 138 patients.
Donovan PJ; Achong N; Griffin K; Galligan J; Pretorius CJ; McLeod DS
J Clin Endocrinol Metab; 2015 May; 100(5):2024-9. PubMed ID: 25719931
[TBL] [Abstract][Full Text] [Related]
19. Regulation of parathyroid hormone-related protein production by a squamous carcinoma cell line in vitro.
Merryman JI; Capen CC; McCauley LK; Werkmeister JR; Suter MM; Rosol TJ
Lab Invest; 1993 Sep; 69(3):347-54. PubMed ID: 8377475
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
